Effect of communicating phenotypic and genetic risk of coronary heart disease alongside web-based lifestyle advice
2019
This work was supported by a European Commission Framework 7 EPIC-CVD Grant agreement no: 279233. NHS Blood and Transplant funded the INTERVAL trial. DNA extraction and genotyping in INTERVAL/INFORM was funded by the National Institute for Health Research. The coordinating team for INTERVAL/INFORM at the Cardiovascular Epidemiology Unit of the University of Cambridge was supported by core funding from: UK Medical Research Council (G0800270), British Heart Foundation (SP/09/002), British Heart Foundation Cambridge Cardiovascular Centre of Excellence and UK National Institute for Health Research Cambridge Biomedical Research Centre. BS was supported by the Medical Research Council [MC_UU_12015/4].
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
26
References
12
Citations
NaN
KQI